Literature DB >> 3440092

Serum morphine concentrations after buccal and intramuscular morphine administration.

A P Fisher1, C Fung, M Hanna.   

Abstract

1. This study compared serum concentrations of morphine after administration of a buccal tablet (25mg) with those after intramuscular injection (10mg). 2. Buccal morphine was administered to eleven healthy volunteers and intramuscular morphine was given to five preoperative surgical patients. Serum morphine concentrations were assayed by high performance liquid chromatography (h.p.l.c.) in samples taken up to 8 h after drug administration. 3. Mean maximum morphine concentrations were eight times lower after buccal administration than after intramuscular injection and occurred at a mean of 4 h later. Individual morphine concentration-time profiles showed marked interindividual variability after administration of the buccal tablet, consistent with considerable variation in tablet persistence time on the buccal mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440092      PMCID: PMC1386390          DOI: 10.1111/j.1365-2125.1987.tb03232.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  Determination of morphine in cerebrospinal fluid and plasma by high-performance liquid chromatography with electrochemical detection.

Authors:  R D Todd; S M Muldoon; R L Watson
Journal:  J Chromatogr       Date:  1982-10-08

2.  Buccal morphine premedication. A double-blind comparison with intramuscular morphine.

Authors:  A P Fisher; P Vine; J Whitlock; M Hanna
Journal:  Anaesthesia       Date:  1986-11       Impact factor: 6.955

3.  Buccal morphine--a new route for analgesia?

Authors:  M D Bell; G R Murray; P Mishra; T N Calvey; B D Weldon; N E Williams
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

  3 in total
  5 in total

Review 1.  Clinical pharmacokinetics of drug administered buccally and sublingually.

Authors:  J G Motwani; B J Lipworth
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

2.  The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.

Authors:  P J Hoskin; G W Hanks; G W Aherne; D Chapman; P Littleton; J Filshie
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

3.  An investigation of premedication with morphine given by the buccal or intramuscular route.

Authors:  K H Simpson; I C Tring; F R Ellis
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

4.  Morphine: pharmacokinetics and clinical practice.

Authors:  P J Hoskin; G W Hanks
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

5.  Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.

Authors:  Renée McCulloch; Mohammed Sattar; Ellen M Henderson; Majella E Lane; Myra Bluebond-Langner
Journal:  Palliat Med       Date:  2017-06-20       Impact factor: 4.762

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.